Prevalence, Predictors, and Outcomes of Type 2 NSTEMI in Hospitalized Patients With COVID-19.
Sahishnu PatelAlexis VisotckyAdam DevineVishwajit KodeSrisha KotloMichael AljadahRodney A SparapaniJacquelyn KulinskiPublished in: Journal of the American Heart Association (2024)
In hospitalized patients with COVID-19, those with a T2MI compared with those without had higher morbidity and mortality. Outpatient anti-hyperglycemic and anti-coagulation use were the only pre-admission factors associated with reduced odds of T2MI.